Skip to main content
. Author manuscript; available in PMC: 2015 Jul 13.
Published in final edited form as: Prostate. 2013 Sep 2;73(15):1681–1689. doi: 10.1002/pros.22705

Fig. 1.

Fig. 1

Genistein enhances the invitro cytotoxicity of cabazitaxel in human mCRPC cells. A: The effect of genistein on mCRPC cell viability. PC3, C4-2, or ARCaPM cells were seeded on 96-well plates and treated with genistein at varying concentrations. Viable cells were measured following a 72-hr incubation. Bars denote the standard error (n = 6). B: Effect of genistein on the in vitro proliferation of PrEC cells. C: The effect of cabazitaxel, in the presence of low-dose genistein or vehicle control (DMSO), on mCRPC cell viability. Viable cells were measured as described above. Combination index (CI) was determined using CalcuSyn software.